Selectins are carbohydrate-binding molecules that bind to fucosylated and sialylated glycoprotein ligands, and are found on endothelial cells, leukocytes and platelets. They are involved in trafficking of cells of the innate immune system, T lymphocytes and platelets. An absence of selectins or selectin ligands has serious consequences in mice or humans, leading to recurrent bacterial infections and persistent disease. Selectins are involved in constitutive lymphocyte homing, and in chronic and acute inflammation processes, including post-ischemic inflammation in muscle, kidney and heart, skin inflammation, atherosclerosis, glomerulonephritis and lupus erythematosus. Selectin-neutralizing monoclonal antibodies, recombinant soluble P-selectin glycoprotein ligand 1 and small-molecule inhibitors of selectins have been tested in clinical trials on patients with multiple trauma, cardiac indications and pediatric asthma, respectively. Anti-selectin antibodies have also been successfully used in preclinical models to deliver imaging contrast agents and therapeutics to sites of inflammation. Further improvements in the efficiency, availability, specificity and pharmacokinetics of selectin inhibitors, and specialized application routes and schedules, hold promise for therapeutic indications.The selectins are a family of three type-I cell-surface glycoproteins: E-, L-and P-selectin [1]. L-selectin is expressed on all granulocytes and monocytes and on most lymphocytes. P-selectin is stored in a-granules of platelets and in Weibel -Palade bodies of endothelial cells, and is translocated to the cell surface of activated endothelial cells and platelets. E-selectin is not expressed under baseline conditions, except in skin microvessels [2], but is rapidly induced by inflammatory cytokines.Selectins show a significant degree of sequence homology among themselves (except in the transmembrane and cytoplasmic domains) and between species (Fig. 1). Analysis of this homology has revealed that the lectin domain, which binds sugars, is most conserved, suggesting that the three selectins bind similar sugar structures. Interestingly, the cytoplasmic and transmembrane domains are highly conserved between species, but not conserved across the selectins. These parts of the selectin molecules are responsible for their targeting to different compartments: P-selectin to secretory granules, E-selectin to the plasma membrane, and L-selectin to the tips of microfolds on leukocytes.
Selectin ligandsThere are many candidate ligands for selectins, but only P-selectin glycoprotein ligand 1 (PSGL-1) has been extensively characterized at the molecular, cellular and functional level (Fig. 2). Knockout mice lacking the gene encoding PSGL-1 [3,4] show delayed neutrophil recruitment and moderate neutrophilia (threefold elevation), similar to that of P-selectin knockout mice [5,6]. In addition to being responsible for ,90% of P-selectin binding, PSGL-1 is also the most important L-selectin ligand in inflammatory settings, where it is presented by already a...